Home
Issues
Aim & Scope
Open Access
Indexing
Why publish with us
Contact
Editorial Board
Instructions to Authors (PDF)
Manuscript Types
Manuscript Formatting
How to submit
Preprints
Authorship & COI
Principles of Transparency Checklist
Publication Ethics and Publication Malpractice Statement
CrossMark
Data Policies
EDITORIAL
Chronic obstructive pulmonary disease: The need for differentiation and individualization of short and long-term treatment of a complex disease
1
2nd Respiratory Medicine Department, University of Athens, “Attikon” General Hospital, Athens Medical School
2
7th Respiratory Medicine Department, “Sotiria” Hospital, Athens, Greece
Corresponding author
Spyros Α. Papiris
2nd Respiratory Medicine Department, University of Athens, “Attikon” General Hospital, Athens Medical School, Athens Greece 1 Rimini street, 12461 Chaidari Athens, Greece
2nd Respiratory Medicine Department, University of Athens, “Attikon” General Hospital, Athens Medical School, Athens Greece 1 Rimini street, 12461 Chaidari Athens, Greece
Pneumon 2015;28(4):318-320
REFERENCES (10)
1.
Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2015. Available from: http://www.goldcopd.org/. Last accessed 17 August 2015.
2.
Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010; 363:1128-38.
3.
D’Urzo A, Donohue JF, Kardos P, et al. A re-evaluation of the role of inhaled corticosteroids in the management of patients with chronic obstructive pulmonary disease. Expert Opin Pharmacother 2015; 16:1845-60.
4.
Martinez-Garcia MÁ, Soler-Cataluña JJ, Donat SY, et al. Factors associated with bronchiectasis in patients with COPD. Chest 2011; 140:1130-7.
5.
O’Brien C, Guest PJ, Hill SL, et al. Physiological and radiological characterization of patients diagnosed with chronic obstructive pulmonary disease in primary care. Thorax 2000; 55:635-42.
6.
Patel IS, Vlahos I, Wilkinson TM, et al. Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 170:400-7.
7.
McGarvey L, Lee AJ, Roberts J, et al. Characterization of the frequent exacerbator phenotype in COPD patients in a large UK primary care population. Respir Med 2015; 109:228-37.
8.
Vogelmeier C, Buhl R, Criee CP, et al. Frequency of COPD exacerbations in the real-life out-patient DACCORD cohort (Abstract). Eur Respir J 2014; 44(Suppl 58):P930.
9.
Izquierdo Alonso JL, Rodríguez Glez-Moro JM. The excessive use of inhaled corticosteroids in chronic obstructive pulmonary disease. Arch Bronconeumol 2012; 48:207-12.
10.
Magnussen H, Disse B, Rodriguez-Roisin R, et al. Withdrawal of inhaled glucocorticoids and exacerbations of COPD. N Engl J Med 2014; 371:1285-94.
| eISSN: | 1791-4914 |
| ISSN: | 1105-848X |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
